France Nuclear Medicine Market Size & Outlook, 2024-2030
Related Markets
France nuclear medicine market highlights
- The France nuclear medicine market generated a revenue of USD 759.6 million in 2024 and is expected to reach USD 1,606.7 million by 2030.
- The France market is expected to grow at a CAGR of 11.7% from 2025 to 2030.
- In terms of segment, diagnostics was the largest revenue generating product in 2024.
- Diagnostics is the most lucrative product segment registering the fastest growth during the forecast period.
Nuclear medicine market data book summary
| Market revenue in 2024 | USD 759.6 million |
| Market revenue in 2030 | USD 1,606.7 million |
| Growth rate | 11.7% (CAGR from 2025 to 2030) |
| Largest segment | Diagnostics |
| Fastest growing segment | Diagnostics |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Therapeutics |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Jubilant Pharmova, Nordion, Bracco, Iren SpA, Abliva AB, Lantheus Holdings Inc, Eckert & Ziegler Bebig SA, Mallinckrodt PLC Ordinary Shares - New, Cardinal Health Inc |
Other key industry trends
- In terms of revenue, France accounted for 4.3% of the global nuclear medicine market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, France nuclear medicine market is projected to lead the regional market in terms of revenue in 2030.
- France is the fastest growing regional market in Europe and is projected to reach USD 1,606.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nuclear Medicine Market Scope
Nuclear Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abliva AB | View profile | 6 | Scheeletorget 1, Medicon Village, Lund, Sweden, 223 81 | https://www.abliva.com |
| Iren SpA | View profile | 10000 | Via Nubi di Magellano, 30, Reggio Emilia, Italy, 42123 | https://www.gruppoiren.it |
| Jubilant Pharmova | View profile | 10001+ | Noida, Uttar Pradesh, India, Asia | https://www.jubilantpharmova.com |
| Lantheus Holdings Inc | View profile | 834 | 201 Burlington Road, South Building, Bedford, MA, United States, 01730 | https://www.lantheus.com |
| Bracco | View profile | 1001-5000 | Milan, Lombardia, Italy, Europe | https://www.bracco.com |
| Nordion | View profile | 251-500 | Kanata, Ontario, Canada, North America | http://nordion.com |
| Eckert & Ziegler Bebig SA | View profile | 501-1000 | Seneffe, Hainaut, Belgium, Europe | http://www.ezag.com/home/ |
| Mallinckrodt PLC Ordinary Shares - New | View profile | 2700 | College Business and Technology Park, Cruiserath, Blanchardstown, Dublin, Ireland, 15 | https://www.mallinckrodt.com |
| Cardinal Health Inc | View profile | 48000 | 7000 Cardinal Place, Dublin, OH, United States, 43017 | https://www.cardinalhealth.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | https://www.gehealthcare.com |
France nuclear medicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nuclear medicine market will help companies and investors design strategic landscapes.
Diagnostics was the largest segment with a revenue share of 93.26% in 2024. Horizon Databook has segmented the France nuclear medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
Rising government initiatives to overcome the shortage of medical isotopes is expected to boost market growth in France. For instance, the French government announced the construction of the Jules Horowitz Reactor at Cadarache, which is expected to be operational in 2022. The reactor is expected to cover nearly one-fourth of Molybdenum production in Europe.
Moreover, presence of Directive 2001/20/EC of April 2001 related to implementation of Good Clinical Practice in study of nuclear medicinal products for human use is expected to drive market growth. The law focuses on harmonizing and simplifying trial procedures for existing & new market players.
Furthermore, according to OECD report 2019, in France, 20 Tc99m-based nuclear medicine diagnostic scans per 1,000 population are performed per year. Out of which, 25% scans are done for bone diseases, 24% for cardiac diseases, and 5% for endocrine disorders. Thus, increasing use of nuclear medicine is expected to boost market growth.
Reasons to subscribe to France nuclear medicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France nuclear medicine market databook
-
Our clientele includes a mix of nuclear medicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France nuclear medicine market , including forecasts for subscribers. This country databook contains high-level insights into France nuclear medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
France nuclear medicine market size, by product, 2018-2030 (US$M)
France Nuclear Medicine Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
